Top Markets
Coin of the day
SynAct Pharma AB SynAct Pharma AB

SynAct Pharma AB

SYNACT
Rank in Stocks #20988
SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS,... SynAct Pharma AB, operating through its subsidiary SynAct Pharma ApS, specializes in creating pharmaceutical interventions for the acute exacerbation of inflammatory conditions. The company's primary investigational compound, AP1189, is currently being developed for the treatment of both rheumatoid arthritis and idiopathic membranous glomerulonephritis. Additionally, SynAct Pharma maintains a collaborative research initiative with the University of Γ–rebro, focusing on the mitigation of inflammation in vascular diseases. Established in 2012, the firm's corporate headquarters are situated in Lund, Sweden.
Share Price
$2.22
Last synced: 2026-08-21
Market Cap
$117.70M
Change (1 day)
2.69%
Change (1 year)
17.26%
Country
SE
Trade SynAct Pharma AB (SYNACT)

Category

Stock price history for SynAct Pharma AB (SYNACT)
Highest end of day price: $2.19 on 2026-08-01

Lowest end of day price: $0.56 on 2016-07-01
Stock price history of SynAct Pharma AB from 2016 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -7.35%
2025 144.78%
2024 17.64%
2023 -89.62%
2022 -48.77%
2021 236.22%
2020 376.82%
2019 16.49%
2018 -27.27%
2017 82.38%
2016 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$547.71 38.62%
US
$1.04K 58.06%
NL
$145.75 437.43%
US
$118.70 -15.60%
AU
$770.19 8.98%
CH